Raw Materials 2021 - Developing an Effective Strategy for Testing Raw Materials in Phase 1 Through Phase 3 Environment

Risk management of raw materials in a GMP environment is an area that is often overlooked as a Company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products
This live training webinar will also examine a variety of the issues surrounding raw materials to include what materials should be tested and to what extent during Phase 1, 2 and 3. It will cover testing requirements
How to develop an overall strategy for testing raw materials in Phase 1 through Phase 3 environment.
What raw material testing is required during various Phases of clinical trials.
What your Certificate of Analysis may tell you.
Speaker:
Barry A. Friedman, Ph.D., is a Senior Consultant in the Biotechnology, Regulatory Compliance and Aseptic Processing arena. From 2000 to 2007, Dr. Friedman was associated with Cambrex Bio Science Baltimore, a contract manufacturer of GMP bulk biopharmaceuticals located in Baltimore